Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""ANTIGENS"" wg kryterium: Temat


Tytuł :
Generation of SARS-CoV-2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases.
Autorzy :
Stamatakis G; Biomedical Sciences Research Center 'Alexander Fleming', 16672 Vari, Attica, Greece.
Samiotaki M; Biomedical Sciences Research Center 'Alexander Fleming', 16672 Vari, Attica, Greece.
Mpakali A; National Centre for Scientific Research 'Demokritos', 15310 Agia Paraskevi, Attica, Greece.
Panayotou G; Biomedical Sciences Research Center 'Alexander Fleming', 16672 Vari, Attica, Greece.
Stratikos E; National Centre for Scientific Research 'Demokritos', 15310 Agia Paraskevi, Attica, Greece.
Pokaż więcej
Źródło :
Journal of proteome research [J Proteome Res] 2020 Nov 06; Vol. 19 (11), pp. 4398-4406. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, Viral*/chemistry
Antigens, Viral*/metabolism
Epitopes*/chemistry
Epitopes*/metabolism
Spike Glycoprotein, Coronavirus*/chemistry
Spike Glycoprotein, Coronavirus*/metabolism
Aminopeptidases/*metabolism
Chromatography, Liquid ; HEK293 Cells ; HLA Antigens/chemistry ; HLA Antigens/metabolism ; Humans ; Peptides/analysis ; Peptides/chemistry ; Peptides/metabolism ; Proteomics/methods ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł :
Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues-authors' reply.
Autorzy :
Liu S; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key, Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Li W; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key, Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Sun J; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key, Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Sep; Vol. 52 (5), pp. 883-884.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Hepatitis B e Antigens*
Hepatitis B, Chronic*/drug therapy
Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Humans ; Kinetics ; Nucleosides/therapeutic use ; RNA
Opinia redakcyjna
Tytuł :
Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues.
Autorzy :
Ding Y; Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, China.
Dou X; Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, China.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Sep; Vol. 52 (5), pp. 881-882.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Hepatitis B e Antigens*
Hepatitis B, Chronic*/drug therapy
Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Humans ; Kinetics ; Nucleosides/therapeutic use ; RNA
Raport
Tytuł :
Understanding and modulating the MR1 metabolite antigen presentation pathway.
Autorzy :
McWilliam HEG; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC, 3010, Australia. Electronic address: .
Salio M; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK. Electronic address: .
Pokaż więcej
Źródło :
Molecular immunology [Mol Immunol] 2021 Jan; Vol. 129, pp. 121-126. Date of Electronic Publication: 2020 Dec 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antigen Presentation/*immunology
Histocompatibility Antigens Class I/*immunology
Mucosal-Associated Invariant T Cells/*immunology
Animals ; Antigens/immunology ; Autoimmunity/immunology ; Histocompatibility Antigens Class II/immunology ; Humans ; Ligands
Czasopismo naukowe
Tytuł :
The role of HLA in Balkan endemic nephropathy.
Autorzy :
Dittrich D; Department of Urology, General Hospital 'Dr. Josip Bencevic', Slavonski Brod, Croatia.
Maskalan M; Tissue Typing Centre, University Hospital Centre Zagreb, Zagreb, Croatia.
Kastelan Z; Department of Urology, University Hospital Centre Zagreb, Zagreb, Croatia.
Palenkic H; Department of Surgery, General Hospital 'Dr. Josip Bencevic', Slavonski Brod, Croatia.
Grubic Z; Tissue Typing Centre, University Hospital Centre Zagreb, Zagreb, Croatia. Electronic address: .
Pokaż więcej
Źródło :
Gene [Gene] 2021 Jan 30; Vol. 767, pp. 145179. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article
MeSH Terms :
Balkan Nephropathy/*genetics
Balkan Nephropathy/*immunology
HLA Antigens/*genetics
Adult ; Aged ; Aged, 80 and over ; Alleles ; Balkan Nephropathy/epidemiology ; Case-Control Studies ; Croatia/epidemiology ; Female ; Gene Frequency/genetics ; Genetic Predisposition to Disease ; HLA Antigens/immunology ; HLA-A Antigens/genetics ; HLA-B Antigens/genetics ; HLA-DRB1 Chains/genetics ; Haplotypes ; Humans ; Male ; Middle Aged ; Polymerase Chain Reaction/methods
Czasopismo naukowe
Tytuł :
Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
Autorzy :
Wang XD; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Feng SJ; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu JP; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Song TR; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Huang ZL; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Fan Y; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Shi YY; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chen LY; Department of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lv YH; West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan, China.
Xu ZL; West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan, China.
Li XH; Department of Health Statistics, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
Wang L; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China.; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lin T; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Number 37, Guoxue Alley, Chengdu, 610041, Sichuan, China. .; Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jan 09; Vol. 21 (1), pp. 41. Date of Electronic Publication: 2021 Jan 09.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B/*virology
Hepatitis B Surface Antigens/*genetics
Kidney Transplantation/*adverse effects
Postoperative Complications/*virology
Adult ; Aged ; DNA, Viral/genetics ; Female ; Hepatitis B/blood ; Hepatitis B/epidemiology ; Hepatitis B Antibodies/blood ; Hepatitis B Core Antigens/genetics ; Hepatitis B Core Antigens/immunology ; Hepatitis B Surface Antigens/immunology ; Hepatitis B virus/genetics ; Hepatitis B virus/immunology ; Humans ; Kidney/virology ; Male ; Middle Aged ; Postoperative Complications/blood ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Retrospective Studies ; Risk Factors ; Tissue Donors/statistics & numerical data ; Transplant Recipients/statistics & numerical data ; Treatment Failure
Czasopismo naukowe
Tytuł :
Antigen presentation genes in gadoid species (haddock: Melanogrammus aeglefinus and Atlantic cod: Gadus morhua) raise questions about cross-presentation pathways and glycosylated beta-2-microglobulin.
Autorzy :
Frenette A; Department of Biology, University of Waterloo, Waterloo, ON, Canada.
Booman M; Department of Ocean Sciences, Memorial University of Newfoundland, St. John's, NL, Canada.
Fujiki K; Department of Biology, University of Waterloo, Waterloo, ON, Canada.
Kales S; Department of Biology, University of Waterloo, Waterloo, ON, Canada.
Ryan C; Department of Biology, University of Waterloo, Waterloo, ON, Canada.
Gamperl AK; Department of Ocean Sciences, Memorial University of Newfoundland, St. John's, NL, Canada.
Dixon B; Department of Biology, University of Waterloo, Waterloo, ON, Canada. Electronic address: .
Pokaż więcej
Źródło :
Molecular immunology [Mol Immunol] 2021 Jan; Vol. 129, pp. 21-31. Date of Electronic Publication: 2020 Nov 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigen Presentation/*genetics
Antigens/*genetics
Cross-Priming/*genetics
Gadus morhua/*genetics
beta 2-Microglobulin/*genetics
Amino Acid Sequence ; Animals ; Antigen Presentation/immunology ; Antigens/immunology ; Cross-Priming/immunology ; Cytoplasm/genetics ; Cytoplasm/immunology ; Endosomes/genetics ; Endosomes/immunology ; Gadus morhua/immunology ; Genome/genetics ; Genome/immunology ; Glycosylation ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Sequence Alignment ; Signal Transduction/genetics ; Signal Transduction/immunology ; T-Lymphocytes/immunology ; Transcription, Genetic/genetics ; Transcription, Genetic/immunology ; beta 2-Microglobulin/immunology
Czasopismo naukowe
Tytuł :
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression.
Autorzy :
Fousek K; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Watanabe J; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Joseph SK; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
George A; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA, United States.
An X; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, USA.
Byrd TT; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Morris JS; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Luong A; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA, United States.; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Martínez-Paniagua MA; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, USA.
Sanber K; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Navai SA; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Gad AZ; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Salsman VS; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Mathew PR; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Kim HN; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA, United States.; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Wagner DL; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Institute of Medical Immunology, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health-Center for Regenerative Therapies (B-CRT), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Brunetti L; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.
Jang A; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.
Baker ML; National Center for Macromolecular Imaging and Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA.
Varadarajan N; Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, USA.
Hegde M; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Kim YM; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA, United States.; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Heisterkamp N; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA, United States.; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.; Department of Systems Biology, Beckman Research Institute City of Hope, Duarte, CA, United States.
Abdel-Azim H; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA, United States. .; University of Southern California Keck School of Medicine, Los Angeles, CA, USA. .
Ahmed N; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA. .; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA. .; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA. .; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. .
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Jan; Vol. 35 (1), pp. 75-89. Date of Electronic Publication: 2020 Mar 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Immunotherapy, Adoptive*/methods
Antigens, CD19/*immunology
Leukemia, B-Cell/*immunology
Leukemia, B-Cell/*metabolism
Receptors, Antigen, T-Cell/*immunology
Receptors, Chimeric Antigen/*immunology
T-Lymphocytes/*immunology
T-Lymphocytes/*metabolism
Animals ; Antigens, CD19/chemistry ; Antigens, Neoplasm ; Biomarkers ; Cell Line, Tumor ; Cytokines/metabolism ; Cytotoxicity, Immunologic ; Disease Models, Animal ; Gene Expression ; Humans ; Leukemia, B-Cell/genetics ; Leukemia, B-Cell/therapy ; Mice, Transgenic ; Protein Binding ; Receptors, Antigen, T-Cell/metabolism ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/metabolism ; Structure-Activity Relationship ; Transduction, Genetic ; Transgenes ; Treatment Outcome ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design.
Autorzy :
Jappe EC; Evaxion Biotech, Bredgade 34E, 1260, Copenhagen, Denmark.; Department of Health Technology, Technical University of Denmark, 2800, Lyngby, Denmark.
Garde C; Evaxion Biotech, Bredgade 34E, 1260, Copenhagen, Denmark.
Ramarathinam SH; Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Passantino E; Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Illing PT; Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Mifsud NA; Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Trolle T; Evaxion Biotech, Bredgade 34E, 1260, Copenhagen, Denmark.
Kringelum JV; Evaxion Biotech, Bredgade 34E, 1260, Copenhagen, Denmark. .
Croft NP; Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. .
Purcell AW; Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Dec 09; Vol. 11 (1), pp. 6305. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genes, MHC Class I/*genetics
High-Throughput Screening Assays/*methods
Histocompatibility Antigens Class I/*immunology
Immunotherapy/*methods
Peptides/*immunology
Alleles ; Antigen Presentation ; Antigens, Neoplasm/immunology ; Antigens, Neoplasm/metabolism ; Cell Line ; Datasets as Topic ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/metabolism ; Hot Temperature/adverse effects ; Humans ; Ligands ; Neoplasms/immunology ; Neoplasms/therapy ; Neural Networks, Computer ; Peptide Library ; Peptides/genetics ; Peptides/metabolism ; Protein Stability ; Proteomics/methods ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł :
Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections.
Autorzy :
Gan W; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China.
Li J; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China.
Zhang C; First Department of Liver Disease, Guangzhou Eighth People's Hospital, Guangzhou, 510000, Guangdong Province, China.
Chen X; Department of Infectious Disease, Guangdong General Hospital, Guangzhou, 510000, Guangdong Province, China.
Lin C; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China. .
Gao Z; Department of Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, 510630, Guangdong Province, China. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Dec 07; Vol. 20 (1), pp. 931. Date of Electronic Publication: 2020 Dec 07.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Multicenter Study
MeSH Terms :
Adenine/*analogs & derivatives
Antiviral Agents/*adverse effects
Hepatitis B e Antigens/*blood
Hepatitis B virus/*genetics
Hepatitis B, Chronic/*drug therapy
Organophosphonates/*administration & dosage
Telbivudine/*adverse effects
Adenine/administration & dosage ; Adult ; Alanine Transaminase/blood ; Antiviral Agents/administration & dosage ; China/epidemiology ; Creatinine/blood ; DNA, Viral/analysis ; Drug Therapy, Combination ; Female ; Glomerular Filtration Rate ; Hepatitis B Surface Antigens/blood ; Hepatitis B Surface Antigens/immunology ; Hepatitis B e Antigens/immunology ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/epidemiology ; Hepatitis B, Chronic/virology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Sustained Virologic Response ; Telbivudine/administration & dosage
Czasopismo naukowe
Tytuł :
The neonatal Fc receptor in mucosal immune regulation.
Autorzy :
Aaen KH; Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Anthi AK; Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Sandlie I; Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Biosciences, University of Oslo, Oslo, Norway.
Nilsen J; Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Mester S; Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Andersen JT; Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.; Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Scandinavian journal of immunology [Scand J Immunol] 2021 Feb; Vol. 93 (2), pp. e13017. Date of Electronic Publication: 2021 Jan 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Histocompatibility Antigens Class I/*immunology
Mucous Membrane/*immunology
Receptors, Fc/*immunology
Animals ; Antigen Presentation/immunology ; Antigen-Antibody Complex/immunology ; Antigens/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Humans ; Immunoglobulin G/immunology ; Immunologic Factors/immunology
Czasopismo naukowe
Tytuł :
Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.
Autorzy :
Fujiki F; Department of Cancer Immunology, Osaka University Graduate School of Medicine, 1-7 Yamada-oka, Suita, Osaka, 565-0871, Japan. .
Tsuboi A; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
Morimoto S; Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
Hashimoto N; Department of Neurosurgery, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Inatome M; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
Nakajima H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, 1-7 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Nakata J; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
Nishida S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Hasegawa K; Department of Cancer Immunology, Osaka University Graduate School of Medicine, 1-7 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Hosen N; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.
Oka Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine, Osaka, Japan.; Department of Immunopathology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Oji Y; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
Sogo S; Department of Cancer Immunology, Osaka University Graduate School of Medicine, 1-7 Yamada-oka, Suita, Osaka, 565-0871, Japan.; Immunology Research Unit, Department of Medical Innovations, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Sugiyama H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, 1-7 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Jan; Vol. 70 (1), pp. 253-263. Date of Electronic Publication: 2020 Jul 22.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, Neoplasm/*immunology
Cancer Vaccines/*immunology
Peptides/*immunology
T-Lymphocytes, Cytotoxic/*immunology
Vaccines, Subunit/*immunology
WT1 Proteins/*immunology
CD5 Antigens/immunology ; Cell Death/immunology ; Cell Proliferation/physiology ; Cells, Cultured ; Humans ; Leukocytes, Mononuclear/immunology ; Neoplasm Recurrence, Local/immunology ; T-Lymphocytes, Helper-Inducer/immunology ; Vaccination/methods
Czasopismo naukowe
Tytuł :
CD66b monocytes represent a proinflammatory myeloid subpopulation in cancer.
Autorzy :
Horzum U; Department of Basic Oncology, Hacettepe University Cancer Institute, 06230, Ankara, Turkey.
Yoyen-Ermis D; Department of Basic Oncology, Hacettepe University Cancer Institute, 06230, Ankara, Turkey.; Department of Immunology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Taskiran EZ; Department of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, Ankara, Turkey.; Department of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Yilmaz KB; Department of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, Ankara, Turkey.; Department of General Surgery, Diskapi Yildirim Beyazit Research and Training Hospital, University of Health Sciences, Ankara, Turkey.; Department of General Surgery, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
Hamaloglu E; Department of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, Ankara, Turkey.; Department of General Surgery, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Karakoc D; Department of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, Ankara, Turkey.; Department of General Surgery, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Esendagli G; Department of Basic Oncology, Hacettepe University Cancer Institute, 06230, Ankara, Turkey. .; Department of Medical and Surgical Research, Institute of Health Sciences, Hacettepe University, Ankara, Turkey. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Jan; Vol. 70 (1), pp. 75-87. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD/*immunology
Cell Adhesion Molecules/*immunology
Inflammation/*immunology
Monocytes/*immunology
Myeloid Cells/*immunology
Neoplasms/*immunology
Adult ; Aged ; Aged, 80 and over ; Cell Movement/immunology ; Cell Proliferation/physiology ; Female ; GPI-Linked Proteins/immunology ; HLA-DR Antigens/immunology ; Humans ; Immunophenotyping/methods ; Interferon-gamma/immunology ; Male ; Middle Aged ; NLR Family, Pyrin Domain-Containing 3 Protein/immunology ; Plasminogen Activator Inhibitor 1/immunology ; Scavenger Receptors, Class E/immunology ; T-Lymphocytes/immunology ; Transcriptome/immunology ; Up-Regulation/immunology
Czasopismo naukowe
Tytuł :
[CD28 costimulation and checkpoint inhibition in T cells].
Autorzy :
Beyersdorf N; Institut für Virologie und Immunbiologie, Universität Würzburg, Versbacher Str. 7, 97078, Würzburg, Deutschland. .
Kerkau T; Institut für Virologie und Immunbiologie, Universität Würzburg, Versbacher Str. 7, 97078, Würzburg, Deutschland. .
Pokaż więcej
Transliterated Title :
CD28-Kostimulation und Checkpointblockade in T-Zellen.
Źródło :
Der Internist [Internist (Berl)] 2020 Jul; Vol. 61 (7), pp. 652-659.
Typ publikacji :
Journal Article; Review
MeSH Terms :
CD28 Antigens*/physiology
T-Lymphocytes/*immunology
Antigens, CD ; CTLA-4 Antigen ; Humans ; Immunotherapy
Czasopismo naukowe
Tytuł :
γδ TCR Recognition of MR1: Adapting to Life on the Flip Side.
Autorzy :
Willcox BE; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK. Electronic address: .
Mohammed F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK.
Willcox CR; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
Trends in biochemical sciences [Trends Biochem Sci] 2020 Jul; Vol. 45 (7), pp. 551-553. Date of Electronic Publication: 2020 Apr 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Histocompatibility Antigens Class I*
Receptors, Antigen, T-Cell, gamma-delta*
Humans ; Ligands ; Minor Histocompatibility Antigens ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł :
Cross-Presentation of Tumor Antigens Is Ruled by Synaptic Transfer of Vesicles among Dendritic Cell Subsets.
Autorzy :
Balan S; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA.
Bhardwaj N; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA; Parker Institute of Cancer Immunotherapy, San Francisco, CA 94129, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer cell [Cancer Cell] 2020 Jun 08; Vol. 37 (6), pp. 751-753.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Antigens, Neoplasm*
Cross-Priming*
Antigens ; Cell Movement ; Dendritic Cells ; Lymph Nodes
Czasopismo naukowe
Tytuł :
Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay.
Autorzy :
Walters LC; Nuffield Department of Medicine Research Building, Roosevelt Drive, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
McMichael AJ; Nuffield Department of Medicine Research Building, Roosevelt Drive, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gillespie GM; Nuffield Department of Medicine Research Building, Roosevelt Drive, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło :
European journal of immunology [Eur J Immunol] 2020 Dec; Vol. 50 (12), pp. 2075-2091. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Histocompatibility Antigens Class I/*immunology
Peptide Fragments/*immunology
Peptides/*immunology
Protein Binding/*immunology
Animals ; CD8-Positive T-Lymphocytes/immunology ; Cytomegalovirus/immunology ; Epitopes, T-Lymphocyte/immunology ; Genes, MHC Class I/immunology ; HIV/immunology ; Histocompatibility Antigens Class II/immunology ; Humans ; Macaca mulatta/immunology ; Simian Acquired Immunodeficiency Syndrome/immunology ; Simian Immunodeficiency Virus/immunology
Czasopismo naukowe
Tytuł :
Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.
Autorzy :
McWilliam HEG; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; .; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3010, Australia.
Mak JYW; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Queensland, Brisbane, QLD 4072, Australia.
Awad W; Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia.
Zorkau M; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Cruz-Gomez S; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Lim HJ; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Yan Y; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Wormald S; Division of Systems Biology and Personalised Medicine, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.
Dagley LF; Division of Systems Biology and Personalised Medicine, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.
Eckle SBG; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Corbett AJ; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Liu H; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3010, Australia.
Li S; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, VIC 3010, Australia.
Reddiex SJJ; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, VIC 3010, Australia.; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC 3052, Australia.
Mintern JD; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3010, Australia.
Liu L; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Queensland, Brisbane, QLD 4072, Australia.
McCluskey J; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Rossjohn J; Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia.; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, CF14 4XN Cardiff, United Kingdom.
Fairlie DP; Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia; .; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Queensland, Brisbane, QLD 4072, Australia.
Villadangos JA; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; .; Department of Biochemistry and Molecular Biology, The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Parkville, VIC 3010, Australia.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Oct 06; Vol. 117 (40), pp. 24974-24985. Date of Electronic Publication: 2020 Sep 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Proteomics*
Endoplasmic Reticulum/*genetics
Histocompatibility Antigens Class I/*genetics
Metabolome/*genetics
Minor Histocompatibility Antigens/*genetics
Antigen Presentation/genetics ; Antigens/genetics ; Antigens/immunology ; CRISPR-Cas Systems/genetics ; Humans ; Ligands ; Lymphocyte Activation/genetics ; Membrane Transport Proteins/genetics ; Molecular Chaperones/genetics ; Molecular Chaperones/immunology ; Mucosal-Associated Invariant T Cells/immunology ; Riboflavin/genetics
Czasopismo naukowe
Tytuł :
Preparation and characterization of monoclonal antibodies recognizing two CD4 isotypes of Microminipigs.
Autorzy :
Ohshima S; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Matsubara T; Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu, Gifu, Japan.
Miyamoto A; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Shigenari A; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Imaeda N; Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu, Gifu, Japan.
Takasu M; Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu, Gifu, Japan.
Tanaka M; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Shiina T; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Suzuki S; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Hirayama N; Institute of Advanced Biosciences, Tokai University, Hiratsuka, Kanagawa, Japan.
Kitagawa H; Department of Veterinary Medicine, Faculty of Veterinary Medicine Okayama University of Science, Imabari, Ehime, Japan.
Kulski JK; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.; Faculty of Health and Medical Sciences, UWA Medical School, The University of Western Australia, Crawley, WA, Australia.
Ando A; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Kametani Y; Division of Basic Medical Science, Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan.; Institute of Advanced Biosciences, Tokai University, Hiratsuka, Kanagawa, Japan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 25; Vol. 15 (11), pp. e0242572. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal/*immunology
CD4 Antigens/*immunology
Swine, Miniature/*immunology
Amino Acid Sequence ; Animals ; Antibody Specificity ; CD4 Antigens/analysis ; CD4 Antigens/chemistry ; CD8 Antigens/analysis ; Cell Line, Tumor ; Female ; Genotype ; HEK293 Cells ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/immunology ; Humans ; Leukocytes, Mononuclear/immunology ; Lymphocyte Activation ; Male ; Mice ; Mice, Inbred BALB C ; Models, Molecular ; Protein Conformation ; Sequence Alignment ; Sequence Homology, Amino Acid ; Specific Pathogen-Free Organisms ; Swine ; Swine, Miniature/genetics ; Transfection
Czasopismo naukowe
Tytuł :
Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer.
Autorzy :
Jäntti T; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.
Luhtala S; Department of Pathology, Seinäjoki Central Hospital, Seinäjoki, Finland.
Mäenpää J; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.; Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Staff S; Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.; Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.; Department of Gynecology and Obstetrics, Tampere University Hospital, Tampere, Finland.
Pokaż więcej
Źródło :
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2020 Nov; Vol. 42 (11), pp. 1010428320971404.
Typ publikacji :
Journal Article
MeSH Terms :
CD8 Antigens/*blood
Carcinoma, Ovarian Epithelial/*blood
Granzymes/*blood
Lymphocytes, Tumor-Infiltrating/*metabolism
Adult ; Aged ; Antigens, CD/blood ; Antigens, Differentiation, Myelomonocytic/blood ; CD4 Antigens/blood ; CD8-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/pathology ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/epidemiology ; Carcinoma, Ovarian Epithelial/pathology ; Disease-Free Survival ; Drug Resistance, Neoplasm/drug effects ; Female ; Forkhead Transcription Factors/blood ; Humans ; Kaplan-Meier Estimate ; Lymphocytes, Tumor-Infiltrating/pathology ; Middle Aged ; Receptors, Cell Surface/blood ; Tumor Microenvironment/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies